Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
about
Topical tacrolimus for atopic dermatitisTopical tacrolimus for atopic dermatitisTopical calcineurin inhibitors for atopic dermatitis: review and treatment recommendationsDexamethasone and FK506 inhibit expression of distinct subsets of chemokines in human mast cellsEczema.Itching for a solutionEczema drugs tacrolimus (Protopic) and pimecrolimus (Elidel): cancer concerns.Atopic and non-atopic eczema.Efficacy and safety of 'wet-wrap' dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature.Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.Pimecrolimus cream 1% in the management of atopic dermatitis in pediatric patients: a meta-analysisConsensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part I): General Management and Topical Treatment.Emotional benefit of cosmetic camouflage in the treatment of facial skin conditions: personal experience and review.Recent developments in the treatment of adult atopic dermatitis.A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema.A systematic review of the safety of topical therapies for atopic dermatitis.Pimecrolimus versus topical corticosteroids in dermatology.What's new in dermatologic therapy.Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate.Wet-wrap treatment in children with atopic dermatitis: a practical guideline.Pimecrolimus for psoriasis.Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs.Antiatopic Dermatitis Effect of Artemisia iwayomogi in Dust Mice Extract-Sensitized Nc/Nga Mice.Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016.Luffa cylindrica suppresses development of Dermatophagoides farinae-induced atopic dermatitis-like skin lesions in Nc/Nga mice.Is the perceived placebo effect comparable between adults and children? A meta-regression analysis.A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal.Topical tacrolimus as treatment of atopic dermatitis.A case of herpes zoster during pimecrolimus use for the treatment of subacute cutaneous lupus erythematosus.Consensus guidelines for the management of atopic dermatitis: an Asia-Pacific perspective.Molluscum contagiosum infection associated with pimecrolimus use in pityriasis alba.Comparable risk of herpes simplex virus infection between topical treatments with tacrolimus and corticosteroids in adults with atopic dermatitis.A comparison of the leaf gel extracts of Aloe ferox and Aloe vera in the topical treatment of atopic dermatitis in Balb/c mice.Eczema (atopic).Anti-inflammatory effect of pimecrolimus in the sodium lauryl sulphate test.A safety review of the medications used to treat atopic dermatitis.Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: results of a randomized, vehicle-controlled, multicenter clinical trial.Prescription Treatment Options.Guidelines for the management of atopic dermatitis (eczema) for pharmacists.
P2860
Q24186624-BD27D5BE-1E72-4025-A8D6-7F3A92DE0925Q24198110-E3C8523B-E336-4247-8D66-73F84F41B08CQ24597375-780ACAED-CD87-492D-80AF-E2CAB8BF07F5Q33669494-C8A830E8-9FDA-477B-89E8-6F304E7B3F93Q33910639-0F91BCB6-9BEF-463A-AE49-108569FA6819Q33926979-373355CF-8CC3-41B1-BB9A-3B40907FC36DQ33938850-52BFB230-EEBD-4AA0-B92D-2C08174D10F9Q34441292-A91E9466-F8BB-4E25-B169-087D9580EC91Q34565637-9C27B756-A20C-43FB-A15D-AD9713BB4817Q35077866-AC30210B-E62A-40BF-AD28-22A7FE978188Q35137660-09951112-C941-4C47-B52C-1BE41D6DD265Q36214247-2EAEDAD0-6F28-48DD-BACD-B2A34699EE3DQ36393754-66724EC8-CD7A-4569-B63E-71ADC4D5B23AQ36459429-61268499-5B44-471E-BCDD-44F9340537F0Q36480608-8D0AD1FB-4FA3-47F0-B545-FC2110E90B22Q36708358-F14C98AA-1DD5-4440-8157-CCBBB4E89F53Q36895865-96A0887A-ADFD-4D8B-AF20-3E8583B3C242Q37131029-9039AED2-2E66-465E-AD4E-385D931FE41EQ37731539-C67D6AC4-FD28-4EC0-A3B9-2B337687481BQ37865056-BD46A2F0-3832-429C-AAEC-C2E99FF1AE56Q37976846-FBD8EB40-0671-4499-B424-A37E7E9A8D45Q38086585-06A766C0-8850-49F1-8065-5CDA254B2D0AQ38266892-2C74F7C1-8300-48A7-AA79-9C112FEC9E7BQ38269229-1ABCD0FC-5EA6-4C95-B414-F0F7B8204122Q38807878-ED386A01-8145-414B-BDF7-8EAB74124CD1Q38946757-9CA32D36-7A44-4E5D-B995-E4A797621CA0Q38959593-D6A60A0E-73EC-46D4-A793-E4AE96C7081AQ40068394-4D5BB6F5-BCBC-45FF-A8EC-C6C550B566D2Q42263734-89B83CE6-CA5A-4D69-87A9-9A6102838219Q43260832-0821FAC8-9D1F-452A-AF67-F49BFA6A4683Q43609061-21DFB0B7-F6F4-4896-A4EA-3B673C2E9012Q45237217-7D606E38-0478-4344-814C-7C7EEC1086C2Q45416616-27BAD18B-0F84-4CFD-B389-336CCDABB234Q46610735-0BB5CFC7-F1FD-4C6E-8CE1-122649F1126BQ46721613-34E74D1C-7014-4FB7-B732-06636A2CA768Q46887367-0A5F5130-224C-4E87-A21A-542110F895CBQ47383323-45E818AE-DC09-4D63-BDA8-6A851D580B28Q48099089-D020E89A-E234-451C-A3E0-6D1158694EDAQ50074353-97A8C365-D957-4F04-8C71-8F973D33DF24Q50144719-6650763A-2CBB-4647-A490-6FC377FC699D
P2860
Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Efficacy and tolerability of t ...... randomised controlled trials.
@ast
Efficacy and tolerability of t ...... randomised controlled trials.
@en
type
label
Efficacy and tolerability of t ...... randomised controlled trials.
@ast
Efficacy and tolerability of t ...... randomised controlled trials.
@en
prefLabel
Efficacy and tolerability of t ...... randomised controlled trials.
@ast
Efficacy and tolerability of t ...... randomised controlled trials.
@en
P2093
P2860
P1433
P1476
Efficacy and tolerability of t ...... randomised controlled trials.
@en
P2093
Hywel C Williams
Paul Dimmock
P2860
P356
10.1136/BMJ.38376.439653.D3
P407
P577
2005-02-24T00:00:00Z